Osteofibrous dysplasia

Last revised by Mohammad Taghi Niknejad on 25 Aug 2022

Osteofibrous dysplasia is a benign fibro-osseous cortical lesion that occurs almost exclusively in the tibia and fibula. It is most commonly seen in the mid-diaphysis of the tibia. Some consider it synonymous with ossifying fibroma because of histological similarities, but it is generally considered a separate entity due to different presentation and treatment.

A commonly used synonym is ossifying fibroma of the long bones.

  • most common in younger patients, e.g. ~10 years of age
    • less commonly reported in older patients, up to 63 years of age 3
  • slight male predilection with M:F ratio of 3:2 3

Most patients present with pain and swelling and may present secondary to a pathological fracture.

Osteofibrous dysplasia is considered a benign, non-neoplastic condition. Some consider it part of a spectrum of osteofibrous dysplasia-like adamantinoma and adamantinoma.

Histology shows trabecular bone woven within fibrous stroma with osteoblastic rimming and mature lamellar bone.

It is closely related to fibrous dysplasia (fibrous dysplasia is predominantly medullary), but the zonal phenomenon and osteoblastic rimming of bony trabeculae are absent in fibrous dysplasia.

Osteofibrous dysplasia and ossifying fibroma of the jaw have similar histological characteristics, but osteofibrous dysplasia shows cytokeratin-positive cells, whereas ossifying fibroma of the jaw shows psammomatous calcification, which are exclusive features.

Although adamantinoma can contain osteofibrous dysplasia-like components, nests or strands of an epithelioid cell are the differentiating feature between adamantinoma and osteofibrous dysplasia.

Adamantinoma with scarce epithelioid component and mostly composed of osteofibrous dysplasia-like tissue are considered osteofibrous dysplasia-like adamantinoma.

Osteofibrous dysplasia is classically a lytic lesion centered in the tibial cortex, often with sclerotic margins. Because of its similarity to adamantinoma, a much more aggressive pathology, a primary issue is differentiating between the two.

Due to intralesional heterogeneity, a needle biopsy may result in diagnostic misclassification, particularly with the underestimation of aggressive lesions. Thus, radiologic-pathologic correlation is important with benign or equivocal biopsy results 3.

Osteofibrous dysplasia tends to be:

  • smaller (mean 6-7 cm versus 10-17 cm for adamantinoma)
  • with more distinct margins
  • less likely to involve the medullary cavity

Plain radiograph remains the initial and chief investigator.

  • location
    • along the long axis: mid-diaphysis, especially anteriorly
    • along the transverse axis: cortical with medullary encroachment
  • consistency
    • lucent or ground-glass
    • lobular to bubbly in appearance
  • margins
    • narrow zone of transition
    • sclerosis is common
  • no nidus
  • no aggressive periosteal reaction
    • benign-appearing periosteal reaction is non-specific and can be seen in all lesions along the osteofibrous dysplasia / adamantinoma spectrum 3
  • there may be pseudotrabeculation and anterior bowing

MRI helps evaluate suspected osteofibrous dysplasia, particularly to assess the extent of intramedullary involvement. Complete medullary cavity involvement is more suggestive of adamantinoma.

  • T1: intermediate signal
  • T2: intermediate-to-high signal
  • T1+C: diffuse and intense enhancement
  • soft tissue component may be present (this is non-specific and can be seen in all lesions along the osteofibrous dysplasia / adamantinoma spectrum 3)
  • no aggressive cortical destruction

Surgery is reserved for lesions that are large or demonstrate aggressive behavior.

They usually have an excellent prognosis and usually stabilize or spontaneously regress once the child is over 10 years old.

It can be locally destructive and may result in pathological fracture, subsequently pseudarthrosis.

Local recurrences can occur after surgery with some aggressive recurrence, possibly due to components of adamantinoma or possible transformation to adamantinoma.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.